Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.59 |
| ▸ | CDK1 | P06493 | 1/20 | 0.57 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.57 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | AMY2A | P04746 | 2/20 | 0.45 |
| ▸ | TYR | P14679 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.44 |
| ▸ | LGALS4 | P56470 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13156776 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL13904361 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21356838 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL670203 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| SCHEMBL20226190 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL3192294 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL24013212 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21114348 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21356841 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE | |
| Melibiose SCHEMBL21356840 | 1.00 | GAA (0.61) | GAACA2CDK1CCNB1ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230304998-A1 | CELLULAR MATERIAL DETECTION PROBES | FluoretiQ Limited (GB) | 2023-09-28 | — | — | US | disclosed |
| US-20170035011-A1 | METHODS OF IMPROVING GERMINATION OF PLANT EMBRYOS | WEYERHAEUSER NR COMPANY | 2017-02-09 | — | — | US | disclosed |
| US-20170035011-A1 | METHODS OF IMPROVING GERMINATION OF PLANT EMBRYOS | WEYERHAEUSER NR COMPANY | 2017-02-09 | — | — | US | disclosed |
| US-20160081336-A1 | MEDIUM WITH A PLANT NON-METABOLIZABLE SUGAR FOR IMPROVING SEED GERMINATION | WEYERHAEUSER NR COMPANY (US) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160081336-A1 | MEDIUM WITH A PLANT NON-METABOLIZABLE SUGAR FOR IMPROVING SEED GERMINATION | NEFM, MGAM, NANS | GAA 265/4885CA2 3625/4885CDK1 1494/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.